Abstract. Cell-matrix interactions are assumed to be important in regulating differentiation and tumor cell growth; however, the precise roles of individual matrix receptors in producing cellular responses are still unclear. We have previously described the etv/~6 integrin, an epithelial cell fibronectin receptor expressed in many carcinoma cell lines. Here we show that heterologous expression of otv/$6 in a human colon carcinoma cell line (SW480) enhances the proliferative capacity of these cells, both in vitro and in vivo in nude mice. This property of av86 correlates with the presence of an ll-amino acid region at the COOH terminus of the B6 cytoplasmic domain. This ll-amino acid sequence is required for the growth stimulatory effect, but not for other functions of the/36 cytoplasmic domain, such as promoting cell adhesion and focal contact localization.
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I
NTEGRINS are heterodimeric cell adhesion receptors composed of two subunits (tx and/~), both of which contain a large extraceUular domain, a transmembrane domain and a short, COOH-terminal cytoplasmic domain (Hynes, 1992) . At least 20 different integrins are known to interact with a variety of extracellular matrix components, including fibronectin, vitronectin, collagens, and laminins. Integrins have been shown to influence a wide array of cellular functions, presumably as a result of interactions between their cytoplasmic domains and intracellular signaling molecules.
The B subunit cytoplasmic domain is required for linking integrins to the cytoskeleton (Hynes, 1992) . In many cases, this linkage is reflected in localization to focal contacts, which is believed to lead to the assembly of signaling complexes that include ct-actinin, talin, and the focal adhesion kinase (pp125-FAK) (Guan and Shalloway, 1992; Kornberg et al., 1992; Otey et al., 1990) . At least three different regions (Reszka et al., 1992) that are required for focal contact localization of B1 integrins have been delineated. These regions contain conserved sequences that are also found in the cytoplasmic domains of the 82, B3, 85, 86, and 87 integrin subunits. The functional differences between these cytoplasmic domains with regard to their signaling capacity have not yet been established.
The t~v86 integrin is a fibronectin receptor expressed predominantly by epithelial cells (Breuss et al., 1993) . In healthy adult primate tissues, B6 mRNA and protein are rarely detected (Breuss et al., 1993, and unpublished data) . In contrast, B6 is expressed during fetal development, wound healing, and in a variety of epithelial tumors (unpublished data). These observations suggested a possible distinct role for this receptor in epithelial cell migration or proliferation.
In the present study, we heterologously expressed the 86 subunit in a colon carcinoma cell line, SW480, from which it is normally absent, and examined the effects of txv~6 on a number of aspects of cell behavior. Expression of this receptor conferred on these cells an enhanced capacity to proliferate. By performing similar experiments with a series of cytoplasmic domain truncation mutants, we identified an l 1-amino acid COOH-terminal region, unique to the/36 subunit, that is required for the proliferation-enhancing activity of the otvB6 integrin.
Geneticin (neomycin analog G418), type I collagen, and BSA were purchased from Sigma Chem. Co. Fibronectin and vitronectin was prepared from human plasma as described (Engvall and Ruoslahti, 1977; Yatohgo et ai., 1988) . Cells were grown in DMEM supplemented with 4.5 gm/liter glucose, L-glntamine, 10% FBS and penicillin/streptomycin, unless stated otherwise.
Preparation of Expression Plasmids
A cDNA containing the entire coding region of human/~6 in the mammalian expression vector pcDNAIneo (Invitrogen, San Diego, CA) was constructed as previously described . To construct truncated versions of pcDNAIneo/36 that lacked selected portions of the cytoplasmic domain, cDNA fragments were amplified by PCR using a 5' upstream primer corresponding to nt 2050-2070 and 3' downstream primers at the following positions: (/) nt 2534-2557 to prepare pcDNAIneo/~6(777t); (2) nt 2516-2536 to prepare pcDNAIneo/36(770t); (3) nt 2447-2467 to prepare pcDNAIneoB6(747t); and (4) nt 2417-2440 to prepare pcDNAIneo/36(738t). The full-length plasmid, pcDNAIneoB6, was used as a template. The 3' primers introduced stop codons to replace amino acids E778, N771, E748, and R739, respectively, and each primer included an XbaI recognition sequence to facilitate ligation into the unique XbaI site in the pcDNAIneo polylinker. Each PCR fragment included a unique BstEII site in/36 (nt 2087). The PCR products were digested with Xbal and BstEII and ligated into pcDNAIneo~6 that had been digested with the same enzymes . The authenticity of each mutant clone was confirmed by dideoxy sequencing using Sequenase 2.0 (Un. States Biochemical Corp., Cleveland, OH).
Transfection of Mammalian Cells
SW480 colon carcinoma cells obtained from the Amer. Type Culture Collection and the adenovirus-transformed human embryonic kidney cell line 293 (obtained from Sarah Bodary, Genentech) were transfected with pcDNAIneo constructs containing wild-type or mutant forms of human ~6, or the expression plasmid only (pcDNAIneo) by the calcium phosphate precipitation method in which the calcium phosphate/DNA precipitates were added to 106 suspended cells that had been removed from tissue culture dishes by trypsinization (Sambrook et ai., 1989) . After transfection, the cells were grown for two days in their usual medium, and then transfectants were selected by growth in the same medium supplemented with the neomycin analog, G418. Individual transfected clones were prepared by limiting dilution cloning in 96-well plates. Stably transfected cells were further cotransfected with expression plasmids containing cDNA encoding firefly luciferase (pRKluc) and a similar plasmid containing a hygromycin resistance gene (pRKhyg) (Crowley et ai., 1993) , and transfectants were selected by growth in both G418 and hygromycin, pRKluc and pRKhyg were girls from Robert Cohen (University of California, San Francisco, CA). Transfected clones were analyzed with a Luciferase Assay System (Promega), and light intensity was measured with a scintillation counter (Nguyen et al., 1988) (LS 5000, Beckmann, Mountain View, CA). The luciferase activity per cell of mock, full-length #6, and truncated/~6 transfectants selected for use in in rive experiments did not differ by more than 6 %. Luciferase activity of each clone was measured on at least two occasions at least three months apart, and remained essentially constant over that time period.
Fluorescence-activated Cell Sorting
/~6-transfected cells were sorted by flow cytometry in the following manner: Transfected cells were allowed to grow in selection medium to •60-80% confluence in 100-mm tissue culture plates. The cells were then harvested by trypsinization and blocked with normal goat serum at 4°C for 10 rain. Cells were washed once with PBS, incubated with primary antibody E7P6 for 20 rain at 4°C, and then washed twice with PBS. Cells were then stained with secondary antibody conjugated with phycoerythrin (Boehringer Marmhelm, Indianapolis, IN) for 20 rain at 4"C, washed twice with PBS, and resuspended in 0.5 ml of PBS with 5 % normal goat serum. The stained cells were sorted using FACS 440 (Becton Dickinson, Rutherford, NJ). The cells in the upper tenth percentile of fluorescence intensity were collected and grown in selection medium. Sorted transfectants were periodically analyzed for t~v/~6 expression using the labeling method described above and comparison and fluorescence intensity with wild-type SW480 ceils as negative control using FACScan (Becton Dickinson). Expression of the integrin subunits a2, a3, c~5, ct6,/31,/~3, and t5 was also analyzed for selected transfectants using monoclonal antibodies P1H5, P1B5, P3D10, J1B5, P5D2, 9(32, and PIF6, respectively.
Cell Proliferation Assays
Bilayer collagen gels comprising a 500-/~1 cell-free underlayer and a 500-/zl upper cell-containing layer were prepared in 24-well tissue culture plates. Cell-free base layers consisted of equal volumes of collagen type I (Sigma, 3.0 mg/mi in 40 mM acetic acid) and a 2x concentrate DMEM without FCS. The pH of the mixture was adjusted to 7.4 by addition of I M sodium hydroxide and the collagen-medium mix then supplemented with 5 % FCS. For the upper collagen layer, harvested cells suspended in FCS were added to the collagen-medium mix. After gelation, 500 ~1 of culture medium (containing 5 % FCS) were added to each well. In all experiments, triplicate gels were prepared containing 104 cells and incubated at 37°C in 5% CO2 for 7 d. At the termination of experiments, the collagen matrix was dissolved with collagenase (Sigma Chem. Co., Cat. No. C5138, 15 mg/rnl in PBS) and total cell number per well estimated by counting cells in a hemocytometer. For antibody inhibition experiments, antibodies were added directly to the collagen medium mix before gelation, and were added to the overlying culture medium 4 d after gelation.
To analyze proliferation in standard culture dishes, 6-well plates were coated with fibronectin (10 #g/ml) or collagen I (10 /~g/ml), and then blocked with 1% BSA. Cells plated in duplicate at a density of 5 x 103 cells/well, were allowed to proliferate in DMEM supplemented with selenium (5 ng/ml), hydrocortisone (1/Lg/mi), insulin (5/~g/rni), transferrin (5/~g/ml), and nonessential amino acids (ICN Biomedicais, Irvine, CA), in the presence or absence of 5 % FCS. On days 1 and 3 after plating, duplicate wells were labeled with [3H]thymidine for 4 h, cells were washed twice with cold PBS, and incorporated label was precipitated with 15% TCA. Precipitates were washed twice with cold 70% ethanol to remove unincorporated label, resuspended in I M NaOH, and neutralized with 1 M HC1. Thymidine incorporation was quantified by scintillation counting (Beckmann LS5000). In parallel triplicate wells, cells were removed and counted at each time point without labeling.
Cell Adhesion Assays
Cell adhesion assays were performed as previously described (Busk et ai., 1992) . Briefly, wells of non-tissue culture-treated polystyrene 96-well flatbottom microtiter plates (Linbro/Titertek, Flow Laboratories, McLean, VA) were coated with various concentrations of fibronectin, vitronectin, or type I collagen, washed with PBS, and then blocked with 1% BSA in serumfree DMEM. Cells were incubated in the presence or absence of the ~1 blocking antibody P5D2 for 15 min at 4°C and were then plated onto the microtiter plates at a density of 50,000 cells/well in 200 t~l of serum-free DMEM containing 0.05 % BSA. The plates were centrifuged (top side up) at 10 g for 5 min, and then incubated for one hour at 37°C in humidified 5 % CO2. Non-adherent cells were removed by centrifugation top side down at 48 g for 5 rain. The attached cells were fixed with 1% formaldehyde and stained with 0.5% crystal violet, and then the wells were washed with PBS. The relative number of cells in each well was evaluated by measuring the absorbance at 595 run in a Microplate Reader (Bio-Rad Labs., Hercules, CA). The data were expressed as the mean of the absorbance of triplicate wells. Measurements of absorbance were determined to be linearly related to input cell number over the range of 10,000-50,000 cells/well.
Immunofluorescent Localization
Cells were harvested by trypsinization before reaching 75 % confluence. 1-3 x 104 cells were plated onto sterile acid-washed 12-mm-diarn glass coverslips that were coated with fibronectin (10 #g/ml) and blocked with 1% BSA in PBS. Coverslips were incubated for 4 h at 37°C in 5% COz. Ceils were rinsed briefly in PBS, fixed with 2 % paraformaldehyde (Fisher Scientific, Pittsburgh, PA) in PBS (pH 7.4) for 10 rain, incubated for 20 rain in 0.1% Triton X-100 in PBS, and processed for immunofluorescence microscopy as follows: cell monolayers were blocked for 20 rain in 1% BSA. Ceils were incubated for 60 min in primary antibody; and then for 30 rain in biotinylated sheep anti-mouse IgG (1:50); and finally for 30 min in streptavidin-fluorescein (1:100). Coverslips were briefly rinsed in distilled water and mounted on microscope slides using Fluoromount G (Fisher Scientific).
Tumor Growth and Metastasis In Vivo
Lucifernse-transfected SW480 cells in log phase growth were removed from tissue culture plates with 0.05 % trypsirdEDTA, and cell counts and viability were assessed by counting cells stained with 0.4% trypan blue in a hemocytometer. Only cell preparations demonstrating greater than 95 % viability were used for injection into mice. Pelleted cells were suspended in BSS, and either 10 ~ or 5 x 106 cells in 50 ttl were injected through a 27-gauge needle into the subcutaneous region of the right flank of 8-wk-old Balb C/nude athymic male mice (Simonsen, S., San Francisco, CA). In additional experiments, tumor cells were either injected directly into the spleen, or into the wall of the cecum. Primary tumors, as well as liver, lung, heart, cecum, brain, and femur were removed after either 6 wk (for animals injected with 5 x 106 cells) or 9 wk (for animals injected with 106 cells). The samples were frozen in liquid nitrogen, and the entire tissue was pulverized with a Bessmer tissue pulverizer (Fisher Scientific), and then incubated with 1 ml of Luciferase Assay lysis buffer (Promega) for one hour at room temperature. Lysates were centrifuged at 13,000 rpm for 20 min, 10 td of supernatant was added to 100 ~1 of luciferin substrate, and luminescence was measured immediately in a luminometer (model 20e, Turner Designs, Sunnyvale, CA) equipped with a 0.25% neutral gray filter. Luciferase activity was determined to be linearly related to cell number over the range of 103-10 s cells/assay using this technique.
Results

Effects of[36 Expression on Proliferation in Collagen Gels
To examine the effects of otv/~6 on epithelial cell behavior, we stably transfected the human colon carcinoma cell line, SW480, with full-length /~6 eDNA. We have previously reported that transfection of these cells with/~6 alone results in surface expression of otv~6 and increased capacity to attach to fibronectin-coated culture dishes . Wild-type SW480 cells migrate poorly on fibronectin, and efficiently form colonies in soft agar. These properties were not affected by heterologous expression of t~v/36 (data not shown). However, in a three-dimensional collagen gel, non-transfected or vector only transfected cells grew poorly, whereas/36-transfected cells formed large branching colonies (Fig. I a) . This difference in colony morphology was accompanied by a significant difference in cell number. To confirm that this proliferative effect was a direct consequence of/~6 expression, and not simply a function of clonal variation, we repeated these experiments with a series of mock and/~6-transfected clones. A total of 14 clones were established (five mock and nine B6 transfectants) and enhanced in vitro growth was observed for all nine/~6 clones tested compared with the five mock-transfected clones (Fig.  1 b) . Incorporation of the anti-ore blocking antibody L230 into the collagen gel had no effect on the proliferation of mock-transfected SW480 cells, but abolished the increase in proliferation in/36-transfected cells (Fig. 1 c) , providing further evidence that the increased proliferation of t 6 transfectants was a direct result of t~v/36 expression.
The nine/~6-transfected clones expressed similar amounts of t 6 on their surface (expression varied by only threefold based on mean fluorescence intensity determined by fluorescence-activated cell analysis). /~6 expression in these transfectants was similar to the level we have previously described for native expression in the pancreatic carcinoma cell line FG . Over this narrow range of expression, we were unable to detect any quantitative relationship between the level of B6 expression and the magnitude of the proliferative response. To determine whether heterologous expression of/~6 affected the expression of other integrin subunits, we analyzed surface expression of ct 2, o~3, or5, tx6, El,/33, B5, and B8 in three mock and three B6-transfected clones by fluorescence-activated cell analysis. As Figure 1 . Effect of B6 transfection on the ability of SW480 ceils to proliferate within three-dimensional collagen type I gels. (a) Photomicrograph of mock and full-length/56 transfectants after 7 d in collagen gels. (b) Total cell counts for each of five mock clones and nine full-length/56 clones. Cells were removed from the gel by treatment with collagenase and counted in a hemocytometer. Bars to the right of each set of individual data points describe the mean + standard error. (c) Effect of blocking antibody against c~v (L230) on total cell counts of mock and Bt-transfected cells allowed to proliferate for 7 d in collagen gels. The non-blocking anti-/56 antibody, RtGg, was used as a control . Shaded bars represent mean values of triplicate wells and lines above each bar represent the standard error of the mean. The results shown are representative of three similar experiment s . ~2  a3  ~5  a6  ~1  B3  B5  ~6   MOCK  C2  420  1301  187  159  1596  9  410  6  F3  517  1196  450  446  1928  9  961  9  F11  512  1229  274  407  1487  9  924  8   SW/~6  C7  700  910  353  353  1775  10  483  318  B2  511  910  290  290  1540  15  411  196  G2  440  1684  638  638  2073  11  412  522 shown in Table I , there was some clonal variation in expression of other integrins among transfected SW480 cell clones, but no consistent difference in expression of or2, or3, or5, or6, or fl 1. None of the clones expressed significant amounts of /$3. There was a tendency for lower expression of/~5 in ~6-transfected clones, perhaps reflecting competition for endogenous tav. This effect is not likely to explain the observed differences in proliferation, however, since mock clone C2 expressed the same level of/$5 as the three/$6 transfectants studied, but did not exhibit enhanced proliferation.
Table L Expression of Various Integrin Subunits (as Measured by Mean Fluorescence Intensity Using FACS) of Mock-and/$-transfected SW480 Clones
Effects of[36 Expression on Cell Proliferation in Two-Dimensional Culture
To determine whether the enhanced proliferation of/$6-transfected SW480 cells in collagen gels required a threedimensional culture system, we examined the proliferation of three mock-and three/$6-transfected clones in standard tissue culture dishes coated with either fibronectin or collagen. Because proliferation in collagen gels required the presence of 5 % FCS, we performed these assays in the presence or absence of serum. As shown in Fig. 2 , mock-and/$6-transfected cells proliferated equally well on both substrates in the presence or absence of serum. Thus, the enhanced proliferation of/$6-transfected SW480 cells appears to require a three-dimensional culture system.
Effects of Cytoplasmic Domain Deletions on ~6-mediated Proliferation in Collagen Gels
The effect of/$6 expression on SW480 cell proliferation raises the question of which structural feature(s) of the oce/$6 receptor are responsible for this effect. The most obvious candidate is the/$6 cytoplasmic domain, which is likely to be involved in transmitting any signals unique to/36. Comparison of the/$6 cytoplasmic domain to the well-characterized cytoplasmic domains of/$1 and t3 reveals that the/$6 cytoplasmic domain contains sequences that are known to be required for focal contact localization (overlined in Fig. 3 a) .
In addition, the /$6 cytoplasmic domain contains an l 1-amino acid COOH-terminal extension that is unrelated to sequences found in other integrins. We speculated that this ll-amino acid extension might be necessary for the proliferation-stimulating effects of ~6. To test this hypothesis, we generated stably transfected SW480 cells expressing a truncated/$6 construct lacking these 11 amino acids. Three additional mutants with more extensive cytoplasmic domain deletions were also tested. Each of the mutants was well expressed on the cell surface as shown by surface staining with the anti-c~vfl6 antibody E7P6 (Fig. 3 b) . Heterologous expression of these mutant versions of/$6, like expression of the full-length version, did not produce any systematic alteration in the expression of other integrins (Table II) . As shown in Fig. 4 a, deletion of the 11-amino acid extension completely abolished the ability of/$6 to promote SW480 cell proliferation in collagen gels. As expected, more extensive or complete deletion of the/$6 cytoplasmic domain similarly abolished fl6-enhanced proliferation. and deletion mutants) were allowed to adhere to individual wells of 96-well microtiter plates which had been coated with fibronectin (3 ~g/ml). 5 x 104 cells were seeded in the presence of/31 blocking antibody P5D2. Non-adherent cells were removed by centrifugation and the attached cells stained with crystal violet . Cell adhesion was quantitated by measuring the absorbance at 595 nm in a Microplate Reader. The data shown represent mean (+ standard error) values from triplicate wells from a single experiment.
Effects of Cytoplasmic Domain Deletions on ~vfl6-mediated Cell Adhesion and on t 6 Localization to Focal Contacts
be responsible for transmitting a proliferative signal unique to fl6. However, an alternative explanation would be that the 11-amino acid extension is required for the overall function of the cytoplasmic domain. To test this possibility, we analyzed the ability of the deletion mutants to perform other known functions of/36, i.e., promotion of adhesion to fibronectin and localization to focal contacts. Removal of the 11-amino acid extension did not abolish the ability of t 6 to promote adhesion to fibronectin, whereas more extensive deletions did (Fig. 4 b) . Transfectants expressing the receptor missing the COOH-terminal 11 amino acids were also able to spread normally on fibronectin in the presence of/$1 blocking antibody (data not shown). Similarly, removal of the COOH-terminal 11 amino acids had no effect on localization of the receptor to focal contacts, but more extensive deletions completely abolished focal contact localization (Fig. 5 ). This finding is consistent with our recent observation that the COOH-terminai 11 amino acids are not required for localization of/$6 to focal contacts in CHO cells . These observations indicate that the portion of the/$6 cytoplasmic domain that is homologous to/$1 and to/$3 is sufficient to support functions that are shared with/$1 and 153 integrins, i.e., localization to focal contacts and promotion of cell adhesion and spreading. In contrast, a unique function o f / $ 6 -stimulation of cell proliferationcritically depends on the presence of the unique 11-amino acid extension. Fn(pg/ml)
Col (pg/ml) Figure 6 . Quantitative effects of expression of full-length or truncated 86 on adhesion of SW480 cells to fibronectin, vitronectin, and type I collagen. (a) SW480 cells transfected with pcDNAIneo, pcDNAIneo/~6, or pcDNAlneo#6777t were allowed to adhere to individual wells of 96-well microtiter plates which had been coated with a range of concentrations of fibronectin. 5 x 104 cells were seeded in the presence of E1 blocking antibody P5D2. The same three cell lines, as well as cells transfected with pcDNAI-neo/~6770t were also allowed to attach to wells coated with a range of concentrations of type I collagen (b) or vitronectin (c). Non-adherent cells were removed by centrifugation and the attached cells stained with crystal violet . Cell adhesion was quantitated by measuring the absorbance at 595 nm in a Microplate Reader. The data shown represent mean (+ standard error) values from the nine data points obtained from triplicate wells in three separate experiments in a and the three data points from triplicate wells in a single experiment in b and c.
To obtain more quantitative information about the relative ability of SW480 cells transfected with intact or truncated 86 cDNA to use 86 for attachment to fibronectin, we performed additional cell adhesion assays examining the attachment of pooled populations of SW480 cells transfected with pcDNAIneo alone, with pcDNAIneo86 or with peDNAIneo86777t to a range of concentrations of fibronectin. Each of these assays was performed on three separate occasions, and mean absorbance values were calculated from the nine data points obtained for each cell line at each concentration. As shown in Fig. 6 a, in the presence of 81-blocking antibody, cells expressing full-length ~6 or 86777t bound equally well to all concentrations of fibronectin, whereas mock transfectants demonstrated little binding to any concentration. To determine whether heterologous expression of intact or truncated 86 altered the ability of SW480 cells to adhere to matrix proteins that are not ligands for etv86, we also performed cell adhesion assays to type I collagen and to vitronectin with the same populations of SW480 cells, and with cells transfected with pcDNAIneo770t. As shown in Fig. 6 (b and c) , all three types of transfectants attached well to type I collagen and to vitronectin, similar to the results we have previously reported for SW480 cells transfected with pcDNAIneo and pcDNAIneo86 .
Effects of[36 Expression on the Proliferation of Embryonic Kidney Cells (293) in Collagen Gels
We were uncertain whether the proliferative effect of 86 was specific to colon carcinoma cells. We therefore stably transfected the human embryonic kidney cell line 293 with pcDNAIneo or pcDNAIneo86, and selected one mock-and two 86-transfected clones for further study. Mock-transfected cells do not express detectable amounts of 86, whereas both 86-transfected clones express levels of 86 comparable to those expressed by transfected SW480 cells (Fig.  7 a) . Both 86-transfected clones proliferated better in collagen gels than did the mock-transfected clone studied (Fig. 7  b) , suggesting that this effect of 86 is not specific for SW480 cells, and can occur in non-tumor cells.
In Vivo Proliferation of SW480 Cells in Nude Mice
To determine whether expression of o~v86 would also increase the growth and/or spread of tumors formed by SW480 cells in vivo, we stably transfected pools of mock-transfected SW480 cells and SW480 cells expressing either full-length or truncated 86 with a mammalian expression plasmid containing a full-length cDNA encoding the enzyme firefly luciferase. We then selected luciferase-transfected clones of each cell type that expressed equal amounts of luciferase activity per cell and injected either 106 or 5 x 10 ~ cells subcutaneously into the right flank of individual nude mice. Each type of cell was injected into six mice (three at 1@ cells/mouse and three at 5 × 10 ~ cells/mouse) and the primary tumors as well as liver, lung, heart, cecum, brain, and femur were removed either 6 (for animals injected with 5 x 106 cells) or 9 wk (for animals injected with 10 ~ cells) later. The number of tumor cells at each site was quantified by measuring the luciferase activity in the homogenized tissue. This method was chosen to avoid the potentially confounding effects on tumor mass of in vivo differences in stroma formation. Tumors formed by cells expressing full-length/36 consistently contained more luciferase activity than tumors formed by either mock-transfected ceils or cells expressing /36 that was truncated to remove the COOH-terminal 11 amino acids (Fig. 8) . None of the animals developed visible metastases at any site, and there was no detectable luciferase activity in any of the organs sampled except for the primary tumors.
Discussion
The results of the present study demonstrate that heterologous expression of the integrin c~v/36 augments cell proliferation in three dimensional collagen gels, and in vivo in nude mice. In addition, these results show that a unique region of the cytoplasmic domain of the/36 subunit is required for this proliferative effect. Other functions of this integrin, including localization to focal contacts and mediation of stable cell adhesion, do not require this unique ll-amino acid COOH terminus, but rather are dependent on the 41-amino acid portion of the/36 cytoplasmic domain that is closely related to other/3 subunits such as/31 and/33.
The observed effect of/36 expression on cell proliferation is biologically plausible given what is known about the pattern of expression of this subunit in normal and pathologic tissues. Using in situ hybridization with a/36-specific riboprobe, we have shown that in healthy adult Rhesus monkeys, /36 mRNA has a quite narrow tissue distribution and is highly expressed only in the secretory uterine endometrium (Breuss et al., 1993) . However,/36 is highly expressed in several epithelial tissues during embryonic development, after injury, and in malignant tumors, all conditions associated with increased proliferation (unpublished observations).
A number of previous studies have demonstrated that the integrin ot5/31 can inhibit tumor growth and anchorageindependent proliferation. For example, overexpression of this integrin in CHO ceils markedly decreased the efficiency with which these cells formed colonies in soft agar, and decreased the capacity of these cells to form tumors in nude mice (Giancotti and Ruoslahti, 1990) . In that study, cells overexpressing a5/31 also demonstrated enhanced ability to incorporate soluble fibronectin into a matrix, an effect the authors thought might contribute to decreased tumorigenesis. The role of a5/31 in inhibiting cell proliferation was also demonstrated by studies in which the erythroleukemia cell line K562 was enriched for increased expression of ~5/31 by several cycles of positive selection through adhesion to fibronectin-coated dishes (Symington, 1990) . K562 cells overexpressing ct5/31 differed from wild-type cells in their diminished capacity to form colonies in soft agar and in their failure to form tumors in nude mice. One possible explanation for the effect of ot5/31 on cell proliferation was suggested by a subsequent study by the same investigator demonstrating that GRGDS peptide, an inhibitor of o~5/31, enhanced anchorage-independent growth and activated two cyclindependent kinases in K562 ceils selected for overexpression of ix5/31 (Symington, 1992) . Additional evidence that ot5/31 can inhibit tumorigenesis came from studies in which clones of CHO cells were selected for decreased levels of o~5/31 (Schreiner et al., 1991) . In that study, t~5/31-deficient clones formed larger tumors in nude mice than did wild-type cells, and in vivo tumor growth was negatively correlated with the level of ct5/31 expression.
The results of the present study appear to contrast with those described above, and suggest that the integrin av/36, which also recognizes fibronectin as a ligand, enhances cell proliferation and in vivo tumor growth. This effect occurs in three-dimensional collagen gels and in vivo in nude mice, but not in collagen or fibronectin-coated tissue culture dishes, suggesting that some aspect of a three-dimensional culture environment may be important for the proliferative effect observed. This effect cannot simply be ascribed to an effect on anchorage independence, since both wild-type and B6-transfected cells grow well in the absence of anchorage, as demonstrated by 100% efficiency in forming colonies in soft agar. This observation suggests that a three-dimensional culture environment and the presence of specific extracellular matrix proteins (e.g., collagen) may be important for the proliferative effect seen.
With regard to stimulation of tumor cell growth, several studies have suggested that the otvB3 integrin plays an important role during the invasive growth phase of malignant melanoma (Albelda et al., 1990; Boukerche et al., 1989; FeldingHabermann et al., 1992) . In one of these studies, melanoma cells lacking o~vB3 were shown to produce smaller tumors in nude mice than their otv/33(+) counterparts (FeldingHabermann et al., 1992) . Recently, the same group has shown that melanoma cells lacking txvB3 undergo apoptosis in collagen gels in the absence of growth factors, but are protected from apoptosis by heterologous expression of av[33 (Montgomery et al., 1994) . In that study, the authors suggested that proteinases secreted by the melanoma cells were degrading the collagen, and revealing a cryptic RGD site that was then recognized by otv/33. It is conceivable that the cells we studied (SW480 and 293 cells) are also capable of secreting proteinases that degrade collagen, and that otv/36, which also recognizes the RGD site in fibronectin (Busk et al., 1992) , is thus interacting directly with degraded collagen. However, in contrast with transfected melanoma cells, we did not observe survival of transfected cells in collagen gels in the absence of serum (data not shown). Furthermore, when we transfected SW480 cells with full-length B3 cDNA, expression of ctvB3 did not enhance the proliferation of these cells (data not shown). Finally, since/~3 does not contain the ll-amino acid sequence implicated in/36-dependent-growth regulation, it is likely that different mechanisms are involved in growth regulation by otvB6 and ave3.
In the present study, subcutaneously injected SW480 cells expressing full-length B6 demonstrated an increased capacity to proliferate in vivo. Because this observation was made with a single tumor cell line in a small number of mice, we cannot determine whether txvB6 generally contributes to in vivo tumor growth. B6-transfected SW480 cells did not form detectable metastases within 6-9 wk. Furthermore, injection of tumor cells directly into the spleen and implantation of tumor cells into the wall of the cecum did not produce significant numbers of metastases (data not shown). Thus, it will be necessary to examine the effects of/36 transfection on carcinoma cells with higher metastatic potential in order to determine the possible role of c~v/36 in tumor invasion, spread, or growth at metastatic sites.
The results of the present study do not allow us to directly determine whether the effects of/36 transfection on cell proliferation require the interaction of txv/36 with specific ligand(s). Since SW480 cells themselves secrete large amounts of fibronectin, it was not possible to study the ability of these cells to proliferate in the absence of ligand for o~vB6. Furthermore, fibronectin may not be the only ligand for this receptor. Recent studies have suggested that o~vfl6 may also be a receptor for the extracellular matrix protein tenascin (Prieto et al., 1993, and unpublished data) . Nonetheless, the notion that otvB6-1igand interaction is required for enhanced proliferation is supported by our finding that the blocking anti-czv antibody, L230, abolished the B6-dependent increment in proliferation. Since the L230 antibody is known to block o~vB6-mediated adhesion to fibronectin ), it appears likely that this antibody inhibits proliferation by preventing czvB6-1igand interactions. Furthermore, we have recently constructed a mutant version of B6 that includes a single point mutation in an aspartic acid residue (Asp m) previously shown to be critical for interactions of/~1 and/33 integrins with ligands (Loftus et al., 1990; Takada et al., 1992) . This mutant B6 forms a heterodimer with w¢ that is well expressed on the cell surface, but is incapable of binding fibronectin (unpublished observations). SW480 cells expressing levels of this mutant receptor comparable to the levels of wild-type receptor in the B6-transfectants described in this manuscript do not demonstrate enhanced proliferation in collagen gels (unpublished observation) . It thus appears likely that ligand binding is important in the enhanced proliferation induced by B6.
Our study implicates the COOH-terminal 11 amino acids of B6 in the generation of a signal that leads to increased proliferation of colon carcinoma cells. This ll-amino acid sequence is not required for B6-mediated adhesion, cell spreading, or focal contact formation, suggesting that B6 enhances growth by directly generating cytoplasmic signals, and not by altering anchorage or shape of the cells. The molecular mechanisms underlying this effect remain to be elucidated. It is possible that the/36 COOH terminus directly interacts with a cytoplasmic signaling molecule. Alternatively, the/36 COOH terminus might modulate the function of another region of the/36 cytoplasmic domain, or of the otv cytoplasmic domain, leading to altered signaling capacity. Finally, it is possible that removing the COOH-terminal 11 amino acids results in a change in conformation in some other region of/36 that is itself responsible for induction of the proliferative response. For example, removal of the COOH-terminal 11 amino acids could lead to a change in the conformation of the remaining conserved region proximal to the transmembrane domain. The transfectants we have generated should be an ideal system to examine these possibilities and to identify the downstream events involved in augmentation of proliferation by the avB6 integrin.
